{"database": "lobbying", "table": "lobbying_activities", "rows": [[1807021, "b4f78fc4-1f20-4118-a43f-cb41598472d5", "Q1", "FOLEY HOAG LLP", 79610, "HORIZON THERAPEUTICS USA (FORMERLY HORIZON PHARMA)", 2016, "first_quarter", "MMM", "Implementation of the Medicaid prescription drug rebate program.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2016-04-13T19:24:51.027000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1807021"], "units": {}, "query_ms": 0.4189969040453434, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}